The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2015

Filed:

Dec. 10, 2009
Applicants:

Douglas Richman, La Jolla, CA (US);

Mary T. Wrin, Fremont, CA (US);

Susan Little, San Diego, CA (US);

Christos J. Petropoulos, Half Moon Bay, CA (US);

Neil T. Parkin, Belmont, CA (US);

Jeannette Whitcomb, San Mateo, CA (US);

Wei Huang, Foster City, CA (US);

Inventors:

Douglas Richman, La Jolla, CA (US);

Mary T. Wrin, Fremont, CA (US);

Susan Little, San Diego, CA (US);

Christos J. Petropoulos, Half Moon Bay, CA (US);

Neil T. Parkin, Belmont, CA (US);

Jeannette Whitcomb, San Mateo, CA (US);

Wei Huang, Foster City, CA (US);

Assignee:

Monogram Biosciences, Inc., South San Francisco, CO (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/70 (2006.01); C12Q 1/68 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); C07K 14/16 (2006.01); C07K 16/08 (2006.01); C07K 14/005 (2006.01); C07K 16/10 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6897 (2013.01); G01N 33/5044 (2013.01); G01N 33/5091 (2013.01); G01N 33/56983 (2013.01); C07K 14/005 (2013.01); C07K 14/16 (2013.01); C07K 14/162 (2013.01); C07K 16/08 (2013.01); C07K 16/10 (2013.01); C12Q 1/703 (2013.01);
Abstract

The present invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.


Find Patent Forward Citations

Loading…